Guillain-Barre Syndrome: all 86 studies
Page 1 of 1. Open to participants first (27), then studies with results posted, then the rest; newest registration first within each.
- Peripheral Nerve Ultrasound in Children With Guillain-Barré SyndromeNot yet recruitingNCT07866898
- Myocardial Changes in Pediatric Guillain-Barré SyndromeNot yet recruitingNCT07842705
- A Study of Empasiprubart as Add-On Therapy to IVIg in Adult Participants With Guillain-Barré SyndromeNot yet recruitingNCT07821762Phase 2
- Efficacy and Safety of Efgartigimod in the Treatment of Guillain-Barré Syndrome(GREAT)Not yet recruitingNCT07806916Phase 2
- Cohort Study on Neuroimmune Diseases in the Reproductive AgeRecruitingNCT07653984
- Tongji NADs CohortNot yet recruitingNCT07333196
- Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating PolyneuropathyNot yet recruitingNCT07121985
- The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.Enrolling by invitationNCT07072676Not applicable
- An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)RecruitingNCT07020819Phase 3
- Noninvasive Support for Acute Respiratory Failure in Guillain-Barré SyndromeRecruitingNCT06996509Not applicable
- Living With Guillain-Barré Syndrome as Children.RecruitingNCT06940908
- Efgartigimod for the Treatment of Guillain-Barré SyndromeNot yet recruitingNCT06885762Phase 2/3
- High-Tech Rehabilitation Pathway for Acute Adult Neuromuscular Diseases - Fit4MedRob-Acute MND ProjectRecruitingNCT06822231Not applicable
- Neuromuscular Complications of MEK Inhibitors: a French Case Series and a Systematic Review of the LiteratureNot yet recruitingNCT06740656
- Our Study Aims to Determine if Nerve Alterations in Acute GBS and CIDP Detectable by Ultrasound Match Electrodiagnostic Findings and if This Method Aids Early Diagnosis, Predict Their Outcomes and Differentiate Between Axonal and Demyelinating Subtypes.RecruitingNCT06615622
- Early vs. Late Tracheostomy in Patients With Guillain -Barre SyndromeRecruitingNCT06612242
- Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular DisordersEnrolling by invitationNCT06605612
- Biomarkers in Autoimmune Disease of Nervous SystemRecruitingNCT06502015
- Prognostic Indicators of Gullian-Barre SyndromeNot yet recruitingNCT06300359
- Predictive Value of Neuromuscular Ultrasound of Cranial Nerves in Guillain-Barré SyndromeNot yet recruitingNCT06200454
- RWE-based Treatment Patterns and Outcomes in CIDPNot yet recruitingNCT05940922
- Gene Sequencing as a Strategy for Identifying Genetic Factors Associated With Serious Adverse Events After Covid-19 Vaccines in Use in BrazilRecruitingNCT05630313
- Genomics and COVID-19 Vaccine Adverse EventsRecruitingNCT05212792
- Comparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre SyndromeNot yet recruitingNCT05114941Not applicable
- Firm Observational Clinical Unicenter Study on Guillain Barré SyndromeRecruitingNCT04829526
- Processing Integration in Neurological Patients Using fMRINot yet recruitingNCT02722070
- Comparative Autoantibody and Immunologic Cell Marker StudyEnrolling by invitationNCT02422875
- A Study to Evaluate the Efficacy and Safety of Eculizumab in Guillain-Barré SyndromeCompletedNCT04752566Phase 3Results posted
- Peripheral Nerve Ultrasound for Diagnosis and Prognosis of Guillain-Barre SyndromeTerminatedNCT04053452Not applicableResults posted
- A Study of Imlifidase in Patients With Guillain-Barré SyndromeCompletedNCT03943589Phase 2Results posted
- Recovery of Visual Acuity in People With Vestibular DeficitsCompletedNCT00411216Not applicableResults posted
- Effect of PNF + Core Strengthening Exercise in Sub-acute Guillain Barre SyndromeCompletedNCT07745556Not applicable
- Exoskeleton Gait Training in Guillain-Barré Syndrome: Safety, Feasibility, Usability, and Longitudinal OutcomesCompletedNCT07556809Not applicable
- Ventilator Weaning Practices in Patients Intubated for Guillain-Barré Syndrome or Myasthenia GravisCompletedNCT07022028
- Evaluation of Usability and Safety of the System Atalante in Patients With High Paraplegia and TetraplegiaCompletedNCT06939634
- Upper Limb Robot-Assisted Therapy in Patients With Guillain-Barré SyndromeActive, not recruitingNCT06620198Phase 4
- Artificial Intelligence-powered Virtual Assistant for Emergency Triage in NeurologyCompletedNCT06334796Early Phase 1
- Ventilator Trigger Sensitivity Adjustment Versus Threshold Inspiratory Muscle Training on Arterial Blood GasesCompletedNCT06167239Not applicable
- Early and Late Prognosis in Patients With Guillain-Barre SyndromeStatus unknownNCT06041451Phase 4
- Prognosis in Patients With Guillain-Barre SyndromeStatus unknownNCT06032741
- Exploring Accessible Beauty for Individuals With Upper Extremity DeficitsCompletedNCT05945784
- Evaluating Efgartigimod in Patients With Guillain-Barré SyndromeWithdrawnNCT05701189Phase 2
- A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Participants With Guillain-Barré Syndrome (GBS)WithdrawnNCT05494619Phase 3
- Effects of Proprioceptive Neuromuscular Training on Sensory and Motor Function in Guillain Barre SyndromeCompletedNCT05491096Not applicable
- RehabGBs: Rehabilitation in People With Guillain-Barré SyndromeCompletedNCT05461898Not applicable
- Diaphragm Thickness by Ultrasonography in Neurological DisordersCompletedNCT05324176Not applicable
- An Assistive Powered Wheelchair: Stage 2 TrialCompletedNCT05292690
- Ultrasonography and Electrophysiology in GBSStatus unknownNCT05284786
- IVIG Versus Plasmapheresis in the Treatment of Guillian Barrie Syndrome PatientsCompletedNCT05104762Phase 2/3
- National Vaccine Adverse Event Reporting Survey and EtiologyStatus unknownNCT05095844
- Predictors and Prognostic Factors of Gullian Barrie Syndrome OutcomeCompletedNCT04927598
- Efficacy and Safety of ANX005 in Subjects With Guillain-Barré SyndromeCompletedNCT04701164Phase 3
- Expression Profile of ERK5 and PKM2 Kinases in Neuroinflammatory Diseases.WithdrawnNCT04674163Not applicable
- Mini-pool Intravenous Immunoglobulin (MP-IVIG) in Guillain-Barré SyndromeStatus unknownNCT04550611Not applicable
- Efficacy of Intravenous Gamma Globulin on Guillain-Barre SyndromeStatus unknownNCT04303962
- Biomarkers in PolyradiculoneuropathiesStatus unknownNCT04249752
- Early Prediction of Respiratory and Autonomic Complications of GBS Using Neuromuscular UltrasoundStatus unknownNCT04166357
- Neuromuscular Ultrasound in Correlation to Neurophysiological FindingsStatus unknownNCT04092140
- A Clinical Study of ANX005 and IVIG in Subjects With Guillain Barré Syndrome (GBS)CompletedNCT04035135Phase 1
- Spontaneous Coronary Artery Dissection (SCAD) and AutoimmunityCompletedNCT03941184
- PatientSpot Formerly Known as ArthritisPowerStatus unknownNCT03840928
- Neurology Inpatient Clinical Education TrialCompletedNCT03826056Not applicable
- Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate AnticoagulationStatus unknownNCT03801135Not applicable
- A Clinical Trial of CK0801 (a New Drug) In Patients With Treatment-Resistant Guillain-Barré Syndrome (GBS)WithdrawnNCT03773328Phase 1
- The Effectiveness and Safety of Human Lumbar Puncture Assist Device (LPat)CompletedNCT03710278
- Feasibility of Two New Software Modules for the Rehabilitation of Patients With Neuromuscular Upper Limb ImpairmentsWithdrawnNCT03268304
- Neurologic Manifestations of the Arbovirus Infection in ColombiaCompletedNCT03206541
- Small Volume Plasma Exchange (SVPE) for Guillain-Barré Syndrome (GBS) PatientsCompletedNCT02780570Phase 2
- sCD163 as a Potential Biomarker in Guillain- Barré SyndromeStatus unknownNCT02582853
- Gastrointestinal Transit Time in Patients With Guillain-Barré SyndromeWithdrawnNCT02459808
- Efficacy and Safety Study of GB-0998 for Guillain-Barré SyndromeCompletedNCT02342184Phase 3
- Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré SyndromeCompletedNCT02221271Phase 3
- Inhibition of Complement Activation (Eculizumab) in Guillain-Barre Syndrome StudyStatus unknownNCT02029378Phase 2
- Change of Nerve Conduction Properties in IVIg Dependent NeuropathiesStatus unknownNCT01655394
- International Guillain-Barré Syndrome Outcome StudyCompletedNCT01582763
- Perception and Multisensory Integration in Neurological Patients Using fMRIStatus unknownNCT01469858Not applicable
- Regional Citrate Anticoagulation in Plasma Exchange TreatmentCompletedNCT01370200Not applicable
- Intravenous Immunoglobulin (IVIG) Versus Plasma Exchange (PE) for Ventilated Children With Guillain Barre Syndrome (GBS)CompletedNCT01306578Not applicable
- Prospective Study on Swallowing/Breathing Interactions in Severe Guillain Barre Syndrome.CompletedNCT01024088
- Brain Computer Interface for Communication in ICU: a Feasibility StudyCompletedNCT01005524
- Safety Study of GBS Following Menactra Meningococcal VaccinationCompletedNCT00575653
- Prednisone Treatment for Vestibular NeuronitisCompletedNCT00271791Phase 2
- The Changes of Cytokines in Guillain Barré Syndrome: the Correlation With Clinical Manifestations and Skin InnervationStatus unknownNCT00173199
- Early Mechanical Ventilation for Guillain Barré SyndromeCompletedNCT00167622Phase 2
- Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-aminopyridineCompletedNCT00056810Phase 2
- Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre SyndromeTerminatedNCT00004833Not applicable